Ambulatory Oxygen for Fibrotic ILD: AmbOx Trial Discussion

Password

Forgot your password?

Select specialty

First name

Last name

Choose Password

Playback speed

10 seconds

By National Jewish Health FEATURING Matthew Koslow, Jeffrey Swigris

0 views

August 17, 2021

Matthew Koslow, MD and Jeffrey Swigris, DO, MS of National Jewish Health discuss the article ...
read more ↘ “Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomized controlled trial” during the 30-minute inaugural webinar of the ILD Journal Club on August 10, 2021.

View the Article Summary:
https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ild-article-summary-ambox_vol1_issue1.aspx
↖ read less

Comments 1